Safety and Efficacy of a Multi-branched Thoracoabdominal Stent Graft System for Thoracoabdominal Aortic Aneurysm.

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorLifetech Scientific (Shenzhen) Co., Ltd.

About this trial

Evaluation of the safety and efficacy of a multi-branched thoracoabdominal stent graft system for thoracoabdominal aortic aneurysm.

Eligibility criteria

Qualifiers

18 years old ≤ age ≤ 80 years old;

Diagnosed as thoracoabdominal aortic aneurysm (based on modified Crawford classification and 2019 European Guidelines for the Treatment of Aortic aneurysm) and should meet at least one of the following conditions;

Maximum diameter of thoracoabdominal aortic aneurysm>50mm;

The diameter has increased by more than 5mm in recent 6 months or the by more than 10mm in recent 1 year;

Disqualifiers

Hemodynamically unstable patients with ruptured thoracoabdominal aortic aneurysms;

Thoracoabdominal aortic dissection;

Mycotic or infectious thoracoabdominal aortic aneurysm;

Patients whose systemic or local infection may increase the risk of intravascular graft infection;

Trial design

Treatments tested in this trial

  • Multi-Branched Thoracoabdominal Stent Graft System

Treatment groups

73 Participants
are divided into 1 treatment group